Kerui Wu Selected Research

Kerui Wu Research Topics

Disease

19	Neoplasms (Cancer) 01/2023 - 04/2015
12	Breast Neoplasms (Breast Cancer) 11/2023 - 02/2013
12	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2013
2	Brain Neoplasms (Brain Tumor) 01/2022 - 06/2019
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 05/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Myocarditis (Carditis) 01/2021
1	Obesity 01/2021
1	Disease Progression 06/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Hand-Foot Syndrome 01/2019
1	Leukopenia 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 12/2022 - 02/2013
3	Nicotine FDA Link 01/2022 - 01/2020
3	LigandsIBA 01/2021 - 04/2015
3	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	LipidsIBA 12/2022 - 12/2017
2	Long Noncoding RNAIBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2018
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2021
2	Estrogen ReceptorsIBA 01/2021 - 01/2021
2	Hormones (Hormone)IBA 01/2021 - 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2023
1	AntigensIBA 01/2023
1	ToyocamycinIBA 01/2022
1	taxifolinIBA 01/2021
1	rhodiolosideIBA 01/2021
1	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 01/2021
1	tetramethylpyrazineIBA 01/2021
1	Lipocalin-2IBA 01/2021
1	CarcinogensIBA 01/2021
1	Chlorogenic AcidIBA 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	SmokeIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Trimetazidine (Vastarel)IBA 01/2021
1	CytokinesIBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Integrin-Binding SialoproteinIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	parthenolideIBA 01/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 06/2019
1	CateninsIBA 06/2019
1	Calcium Channels (Calcium Channel)IBA 06/2019
1	helichrysetinIBA 05/2019
1	TegafurIBA 01/2019
1	Marsdeniae tenacissimae extractIBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	XELOXIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	fludarabineIBA 01/2018
1	XIST non-coding RNAIBA 01/2018
1	Nucleic AcidsIBA 12/2017
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Untranslated RNA (Noncoding RNA)IBA 01/2016
1	pterostilbeneIBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 04/2015
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 04/2015
1	CC ChemokinesIBA 04/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2015
1	ProstaglandinsIBA 04/2015
1	Matrix Metalloproteinases (MMPs)IBA 04/2015

Therapy/Procedure

3	Therapeutics 06/2019 - 01/2016
2	Immunotherapy 11/2023 - 01/2023
1	Ovariectomy (Oophorectomy) 01/2021
1	Radiotherapy 06/2019
1	Drug Therapy (Chemotherapy) 01/2019